21481088

Yilmaz M

2011

Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.

21481376

Bellver J

2011

Endometrial gene expression in the window of implantation is altered in obese women especially in?association with polycystic ovary syndrome.

21484319

Ghandi S

2011

The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study.

21485070

Li XB

2011

[Distribution of Chinese medicine syndrome patterns and its laws in patients with polycystic ovarian syndrome].

21485085

Wang YR

2011

[Effect of sequential method of nourishing yin and tonifying yang on serum sex hormone levels in rats with polycystic ovary syndrome].

21486668

Berent-Spillson A

2011

Insulin resistance influences central opioid activity in polycystic ovary syndrome.

21487075

Raja-Khan N

2011

The physiological basis of complementary and alternative medicines for polycystic ovary syndrome.

21492415

Zhang X

2011

Association of TRB3 Q84R polymorphism with polycystic ovary syndrome in Chinese women.

21495802

Wang Q

2011

Association between serum adipocyte factor level and insulin resistance in polycystic ovarian syndrome.

21496806

Papaleo E

2011

Inositol effects on ovulation induction in patients with polycystic ovary syndrome.

21496811

Rizzo P

2011

Comments on the role of inositol supplementation in patients with polycystic ovary syndrome.

21499461

Najem F

2008

Clinical and Biochemical Characteristics of Polycystic Ovary Syndrome in Benghazi- Libya; A Retrospective study.

21500461

Dum?chi??-Gargu G

2010

[Polycystic ovary syndrome--genetic considerations].

21501001

Markantes G

2011

Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 ?g ethinyl estradiol and 2 mg cyproterone acetate.

21505042

Taylor MC

2011

Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome.

21505333

He RH

2011

How to deal with fluid in the endometrial cavity during assisted reproductive techniques.

21508129

Schmidt J

2011

Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls.

21508897

Shivaswamy V

2011

Tacrolimus and sirolimus induce reproductive abnormalities in female rats.

21510080

Pinkhasov BB

2010

[Nature of obesity and the rate of aging in women with reproductive function disturbances].

21510912

Tersigni C

2011

Adipokines: new emerging roles in fertility and reproduction.

21511534

Fernandez H

2011

Ovarian drilling for surgical treatment of polycystic ovarian syndrome: a comprehensive review.

21511711

Pelzer ES

2011

Microbial colonization of follicular fluid: alterations in cytokine expression and adverse assisted reproduction technology outcomes.

21514580

Cittadini E

2011

The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen.

21514585

Li Y

2011

Follicle-stimulating hormone suppressed excessive production of antimullerian hormone caused by?abnormally enhanced promoter activity in?polycystic ovary syndrome granulosa cells.

21514928

Elmashad AI

2011

Impact of laparoscopic ovarian drilling on anti-M?llerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women with anovulatory polycystic ovary syndrome.

21518135

Weerakiet S

2011

Randomized controlled trial of different doses of metformin for ovulation induction in infertile women with polycystic ovary syndrome.

21518564

Liao L

2011

Metformin versus metformin plus rosiglitazone in women with polycystic ovary syndrome.

21521255

Joharatnam J

2011

Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters.

21521284

Sidhwani S

2011

Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight.

21521311

Rotondi M

2011

Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome.

21521934

Anaforoglu I

2011

Relative associations of polycystic ovarian syndrome vs metabolic syndrome with thyroid function, volume, nodularity and autoimmunity.

21521935

Kurdoglu Z

2012

Oxidative status and its relation with insulin resistance in young non-obese women with polycystic ovary syndrome.

21524038

Allen G

2011

FPIN?s clinical inquiries. Secondary causes of obesity.

21527854

Rashidi B

2011

Simvastatin effects on androgens, inflammatory mediators, and endogenous pituitary gonadotropins among patients with PCOS undergoing IVF: results from a prospective, randomized, placebo-controlled clinical trial.

21528473

Lewandowski KC

2011

The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).

21528474

Lenarcik A

2011

Hormonal abnormalities in first-degree relatives of women with polycystic ovary syndrome (PCOS).

21529351

Dafopoulos K

2011

Inhibin secretion in women with the polycystic ovary syndrome before and after treatment with progesterone.

21530057

Hu W

2011

Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome.

21530058

De Leo V

2011

The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications.

21530059

Graupp M

2011

Association of genetic variants in the two isoforms of 5?-reductase, SRD5A1 and SRD5A2, in lean patients with polycystic ovary syndrome.

21530060

Maciel GA

2011

Influence of LH and high-density lipoprotein cholesterol (HDL-C) on metformin response in women with polycystic ovary syndrome.

21535308

Bhattacharya SM

2011

Prevalence and risk of metabolic syndrome in adolescent Indian girls with polycystic ovary syndrome using the 2009 'joint interim criteria'.

21536229

Yanes LL

2011

Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome.

21536277

Billecke SS

2011

Pitfalls in the assessment of PON1 status in clinical populations.

21538144

de Oliveira Baraldi C

2011

Metformin pharmacokinetics in nondiabetic pregnant women with polycystic ovary syndrome.

21543377

Koiou E

2011

Circulating platelet-derived microparticles are elevated in women with polycystic ovary syndrome diagnosed with the 1990 criteria and correlate with serum testosterone levels.

21543511

Velazquez MA

2011

In vivo oocyte developmental competence is reduced in lean but not in obese superovulated dairy cows after intraovarian administration of IGF1.

21547256

Fulghesu AM

2011

IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance.

21547513

Dilbaz B

2011

Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes.

21549367

Lin YH

2011

Antim?llerian hormone and polycystic ovary syndrome.

21549510

Jedel E

2011

Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndrome.

21550041

McCormick BA

2011

Endometrial thickness predicts endometrial hyperplasia in patients with polycystic ovary syndrome.

21550088

Li HW

2011

Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome.

21550852

He D

2011

Meta-analysis of letrozole versus clomiphene citrate in polycystic ovary syndrome.

21552164

Tartagni M

2011

Pregnancy in a woman with premature ovarian insufficiency undergoing intracytoplasmic sperm injection after pretreatment with estrogens followed by therapy with estrogens associated with ovarian stimulation with gonadotropins: remarks about oocyte and embryo quality.

21553361

Livadas S

2011

Menstrual irregularities in PCOS. Does it matter when it starts?.

21553368

Cupisti S

2011

The different phenotypes of polycystic ovary syndrome: no advantages for identifying women with aggravated insulin resistance or impaired lipids.

21556889

Reinblatt SL

2011

Controversies in IVM.

21557696

Torun AN

2011

Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered.

21557697

Zhang J

2011

The plasma level and gene expression of resistin in polycystic ovary syndrome.

21557698

Pereira M Jr

2011

Involvement of GDF-9, leptin, and IGF1 receptors associated with adipose tissue transplantation on fertility restoration in obese anovulatory mice.

21557918

Liu Y

2011

Abnormal expression of uncoupling protein-2 correlates with CYP11A1 expression in polycystic ovary syndrome.

21561809

Abir R

2011

Invited commentary: a single nucleotide polymorphism in BMP15 is associated with high response to controlled ovarian hyperstimulation.

21562798

McGowan MP

2011

Polycystic ovary syndrome: a common endocrine disorder and risk factor for vascular disease.

21562964

Kunt C

2011

Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.

21565677

Bentley-Lewis R

2011

Ovarian hypertension: polycystic ovary syndrome.

21569072

Gangale MF

2011

Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome.

21573681

Bingol B

2011

Prenatal diagnosis of Comel-Netherton syndrome with PGD, case report and review article.

21575217

Paredes AH

2011

Sympathetic nerve activity in normal and cystic follicles from isolated bovine ovary: local effect of beta-adrenergic stimulation on steroid secretion.

21575449

Ma CS

2011

[Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].

21575945

Chang CY

2011

Lower serum apelin levels in women with polycystic ovary syndrome.

21576081

Nahuis MJ

2011

Long-term outcomes in women with polycystic ovary syndrome initially randomized to receive laparoscopic electrocautery of the ovaries or ovulation induction with gonadotrophins.

21577021

Koiou E

2011

The phenotypes of polycystic ovary syndrome defined by the 1990 diagnostic criteria are associated with higher serum vaspin levels than the phenotypes introduced by the 2003 criteria.

21584501

Kim JH

2011

Association study between the -866G/A polymorphism in the promoter of uncoupling protein-2 gene and polycystic ovary syndrome.

21586896

Gambineri A

2011

Basal insulin-like factor 3 levels predict functional ovarian hyperandrogenism in the polycystic ovary syndrome.

21591394

Chernukha GE

2010

[Drug correction of hormonal disturbances and risk factors of cardiovascular complications in women of reproductive age with polycystic ovary syndrome].

21592169

Hosseinpanah F

2011

The lack of association between polycystic ovary syndrome and metabolic syndrome: Iranian PCOS prevalence study.

21593045

Swanton A

2011

Do women with ovaries of polycystic morphology without any other features of PCOS benefit from short-term metformin co-treatment during IVF? A double-blind, placebo-controlled, randomized trial.

21593108

Eriksen MB

2011

Intact primary mitochondrial function in myotubes established from women with PCOS.

21594601

Abu Hashim H

2011

Does laparoscopic ovarian diathermy change clomiphene-resistant PCOS into clomiphene-sensitive?

21600576

Yildizhan R

2011

Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome.

21600812

Nidhi R

2011

Prevalence of polycystic ovarian syndrome in Indian adolescents.

21602145

Lin Y

2011

[Relation between insulin resistance and insulin receptor gene methylation in the endometrium of patients with polycystic ovary syndrome].

21602314

Wetzka B

2011

Anti-Mullerian hormone confirms the novel classification of female functional androgenization including polycystic ovary syndrome.

21602454

Oberfield SE

2011

Approach to the girl with early onset of pubic hair.

21605000

L?zaro I

2011

Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess.

21605157

Livadas S

2011

Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome.

21605417

Sabatini ME

2011

Metformin therapy in a hyperandrogenic anovulatory mutant murine model with polycystic ovarian syndrome characteristics improves oocyte maturity during superovulation.

21606131

Kj?tr?d SB

2011

Use of metformin before and during assisted reproductive technology in non-obese young infertile women with polycystic ovary syndrome: a prospective, randomized, double-blind, multi-centre study.

21606132

Legro RS

2011

Metformin as adjuvant therapy to IVF in women with PCOS: when is intention-to-treat unintentional?

21606667

Calogero AE

2011

Understanding polycystic ovarian syndrome pathogenesis: an updated of its genetic aspects.

21606690

Saha SA

2011

Thrombocytosis in patients with polycystic ovary syndrome: reactive or culpable?

21608442

Unfer V

2011

Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.

21609197

?lvarez-Blasco F

2011

Diet composition and physical activity in overweight and obese premenopausal women with or without polycystic ovary syndrome.

21611153

Jones MR

2011

Harnessing expression data to identify novel candidate genes in polycystic ovary syndrome.

21613813

Wehr E

2011

Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: a pilot study.

21614496

Li C

2011

Prognostic value of total testosterone for pregnancy during treatment in patients with clomiphene-citrate-resistant polycystic ovary syndrome: a pilot study.

21615238

Ribeiro AL

2012

Myeloperoxidases and polycystic ovary syndrome.

21616917

Moran LJ

2011

Vascular function in the diagnostic categories of polycystic ovary syndrome.

21621772

Gurgan T

2011

Intravenous calcium infusion as a novel preventive therapy of ovarian hyperstimulation syndrome for patients with polycystic ovarian syndrome.